Get started
Author

Shengfa Su

Observed names: S. Fa Su, S. SU, S. Su, S.F. Su, Sheng-Fa Su, ShengFa Su, Sheng‐Fa Su, Su, Shengfa
Observed institutions: Guiyang Medical University, Sun Yat-sen University, Guizhou Cancer Hospital, Affiliated Hospital of Guizhou Medical University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China
ORCID: 0000-0002-6429-0081
Observed ORCID: 0000-0002-6429-0081
OpenAlex ID: A5022808022
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
2013 · Xueming Sun, Shengfa Su, et al. · Radiotherapy and Oncology · 554
Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China
2015 · ShengFa Su, Tao Li, et al. · International Journal of Radiation Oncology*Biology*Physics · 47
PDF
International consensus on radiotherapy in metastatic non-small cell lung cancer
2022 · Zhengfei Zhu, Jianjiao Ni, et al. · Translational Lung Cancer Research · 39
PDF
Effect of PD-1 Inhibitor Combined with X-Ray Irradiation on the Inflammatory Microenvironment and Lung Tissue Injury in Mice
2022 · Yichao Geng, Shengfa Su, et al. · Journal of Inflammation Research · 22
PDF
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study
2013 · Sheng-Fa Su, Yin-Xiang Hu, et al. · BMC Cancer · 21
PDF
The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
2014 · ShengFa Su, YinXiang Hu, et al. · Radiation Oncology · 18
PDF
Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study
2014 · Wei-Wei Ouyang, Sheng-Fa Su, et al. · BMC Cancer · 16
PDF
PD-1 Inhibitor Aggravate Irradiation-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads Signaling Pathway via GSDMD-Mediated Pyroptosis
2024 · Bibo Wu, Shasha Zhao, et al. · Inflammation · 12
Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change
2021 · Qingsong Li, Na Liang, et al. · Frontiers in Oncology · 8
PDF
Randomized phase II study of pemetrexed-cisplatin or docetaxel-cisplatin plus thoracic intensity-modulated radiation therapy in patients with stage IV lung adenocarcinoma.
2019 · Sheng-Fa Su, Mei Li, et al. · PubMed Central · 8
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury
2022 · Jie Bai, Bibo Wu, et al. · Journal of Inflammation Research · 7
PDF
Genetic characteristics of a patient with multiple primary cancers: A case report
2021 · Wei-Wei Ouyang, Qing-Yun Li, et al. · World Journal of Clinical Cases · 7
[Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer].
2014 · Min Su, Yu Gu, et al. · PubMed · 7
Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy
2014 · Wei-Wei Ouyang, Sheng-Fa Su, et al. · Radiation Oncology · 6
PDF
Effectiveness and safety of pirfenidone for radiation-induced lung injury in non-small cell lung cancer: a retrospective pilot study
2025 · Xian Liu, Fangyang Lu, et al. · BMC Cancer · 5
PDF
Prognostic Model to Predict Overall Survival for Metastatic Non-Small Cell Lung Cancer Patients Treated With Chemotherapy Combined With Concurrent Radiation Therapy to the Primary Tumor: Analysis From Two Prospective Studies
2021 · Ling-Feng Liu, Qing-Song Li, et al. · Frontiers in Oncology · 5
PDF
Simultaneous integrated boost of intensity‐modulated radiation therapy to Stage II‐III non‐small cell lung cancer with metastatic lymph nodes
2020 · Qing‐Song Li, Na Liang, et al. · Cancer Medicine · 5
PDF
Impact of intensity-modulated radiotherapy on the 6th edition of UICC/AJCC staging system in nasopharyngeal carcinoma
2010 · Weiwei Xiao, Tai‐Xiang Lu, et al. · Zhonghua fangshe zhongliuxue zazhi · 5
Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study
2023 · Qingsong Li, Cheng Hu, et al. · Cancer Medicine · 4
PDF
Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment
2022 · Qingsong Li, Cheng Hu, et al. · Cancer Management and Research · 4
PDF
Recombinant human endostatin combined with radiotherapy promotes cardiomyocyte apoptosis in rats via TGFβ1/Smads/CTGF signaling pathway
2022 · Weiwei Ouyang, Shimei Fu, et al. · BMC Cardiovascular Disorders · 4
PDF
Pemetrexed plus cisplatin versus docetaxel plus cisplatin for stage IV lung adenocarcinoma based on propensity score matching
2018 · ShengFa Su, LingFeng Liu, et al. · Anti-Cancer Drugs · 4
Unmodified RNA sequences form unusual stable G-quadruplexes with potential anti-RSV and anti-angiogenesis applications
2025 · Rui-Qing Tian, Yue Gao, et al. · Communications Biology · 3
Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy
2023 · Qingsong Li, Cheng Hu, et al. · Frontiers in Oncology · 3
PDF
Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study
2025 · Ya Li, Ji Xia, et al. · Frontiers in Immunology · 2
PDF
Works count: 68
Citation count: 833
H-index: 8
I10-index: 8
Year
Topic
Type